|
Name |
2-Ethyl-4-methylphenol
|
Molecular Formula | C9H12O | |
IUPAC Name* |
2-ethyl-4-methylphenol
|
|
SMILES |
CCC1=C(C=CC(=C1)C)O
|
|
InChI |
InChI=1S/C9H12O/c1-3-8-6-7(2)4-5-9(8)10/h4-6,10H,3H2,1-2H3
|
|
InChIKey |
AVVVXUXMKWPKAJ-UHFFFAOYSA-N
|
|
Synonyms |
2-Ethyl-4-methylphenol; 2-Ethyl-p-cresol; 3855-26-3; p-Cresol, 2-ethyl-; Phenol, 2-ethyl-4-methyl-; L4679W99NC; 2-ethyl-4-methyl-phenol; EINECS 223-361-8; UNII-L4679W99NC; 2-Ethyl-p-cresol, 8CI; SCHEMBL1023280; DTXSID30191879; ZINC5688568; 2-Ethyl-4-methylphenol, AldrichCPR; AKOS022633580; MB23622; CS-0237326; FT-0703977; EN300-182300; Q27282679
|
|
CAS | 3855-26-3 | |
PubChem CID | 77462 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 136.19 | ALogp: | 2.7 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.629 |
Caco-2 Permeability: | -4.357 | MDCK Permeability: | 0.00002620 |
Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0.008 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.348 |
30% Bioavailability (F30%): | 0.878 |
Blood-Brain-Barrier Penetration (BBB): | 0.584 | Plasma Protein Binding (PPB): | 90.77% |
Volume Distribution (VD): | 1.59 | Fu: | 9.85% |
CYP1A2-inhibitor: | 0.912 | CYP1A2-substrate: | 0.951 |
CYP2C19-inhibitor: | 0.641 | CYP2C19-substrate: | 0.567 |
CYP2C9-inhibitor: | 0.25 | CYP2C9-substrate: | 0.802 |
CYP2D6-inhibitor: | 0.795 | CYP2D6-substrate: | 0.896 |
CYP3A4-inhibitor: | 0.103 | CYP3A4-substrate: | 0.35 |
Clearance (CL): | 14.167 | Half-life (T1/2): | 0.849 |
hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.036 |
Drug-inuced Liver Injury (DILI): | 0.044 | AMES Toxicity: | 0.165 |
Rat Oral Acute Toxicity: | 0.155 | Maximum Recommended Daily Dose: | 0.14 |
Skin Sensitization: | 0.792 | Carcinogencity: | 0.289 |
Eye Corrosion: | 0.972 | Eye Irritation: | 0.992 |
Respiratory Toxicity: | 0.349 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000498 | 0.636 | D06GIP | 0.474 | ||||
ENC000329 | 0.545 | D02ZJI | 0.333 | ||||
ENC000172 | 0.543 | D0K5CB | 0.333 | ||||
ENC001026 | 0.474 | D0T7OW | 0.326 | ||||
ENC000413 | 0.444 | D04PHC | 0.319 | ||||
ENC000985 | 0.421 | D0YF3X | 0.315 | ||||
ENC000180 | 0.417 | D0I8FI | 0.314 | ||||
ENC000407 | 0.405 | D07MOX | 0.311 | ||||
ENC001052 | 0.395 | D0S5LH | 0.311 | ||||
ENC000552 | 0.385 | D08HUC | 0.309 |